Iressa Interactions
There are 231 drugs known to interact with Iressa (gefitinib), along with 6 disease interactions. Of the total drug interactions, 38 are major, 189 are moderate, and 4 are minor.
- View all 231 medications that may interact with Iressa
- View Iressa disease interactions (6)
Most frequently checked interactions
View interaction reports for Iressa (gefitinib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Aubagio (teriflunomide)
- Avastin (bevacizumab)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Braftovi (encorafenib)
- Brineura (cerliponase alfa)
- Caprelsa (vandetanib)
- Cosentyx (secukinumab)
- Crixivan (indinavir)
- Dupixent (dupilumab)
- Entresto (sacubitril / valsartan)
- Entyvio (vedolizumab)
- Erivedge (vismodegib)
- erlotinib
- Esbriet (pirfenidone)
- Gazyva (obinutuzumab)
- Genvoya (cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)
- Gilotrif (afatinib)
- Humira (adalimumab)
- Idhifa (enasidenib)
- Imbruvica (ibrutinib)
- Imfinzi (durvalumab)
- Inderal (propranolol)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Letairis (ambrisentan)
- Mekinist (trametinib)
- Methotrexate LPF Sodium (methotrexate)
Iressa disease interactions
There are 6 disease interactions with Iressa (gefitinib) which include:
- dermatologic toxicities
- GI disorders
- ocular disorders
- pulmonary toxicity
- liver disease
- renal dysfunction
More about Iressa (gefitinib)
- Iressa consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.